Substitutes for Afclav 375 Tablet
Substitutes can only be ordered…

649 Substitutes
Sorted ByRelevancePrice
  • Detail
  • Moxikind-CV 375 Tablet
    10 tablets
    Mankind Pharma Ltd
    ₹ 75
    50% offMRP₹ 150
    save 18% more per Tablet
  • Clavam 375 Tablet
    10 tablets
    Alkem Laboratories Ltd
    ₹ 99.5
    50% offMRP₹ 199
    pay 9% more per Tablet
  • Moxclav 375 Tablet
    10 tablets
    Sun Pharmaceutical Industries Ltd
    ₹ 132
    50% offMRP₹ 264
    pay 44% more per Tablet
  • Sensiclav 375 Tablet
    6 tablets
    Macleods Pharmaceuticals Pvt Ltd
    ₹ 68.4
    50% offMRP₹ 136.7
    pay 24% more per Tablet
  • Mpx-CV 375mg Tablet
    6 tablets
    Hetero Drugs Ltd
    ₹ 45.7
    50% offMRP₹ 91.3
    save 17% more per Tablet
  • Mega-CV 375 Tablet
    6 tablets
    Aristo Pharmaceuticals Pvt Ltd
    ₹ 53
    50% offMRP₹ 105.95
    save 4% more per Tablet
  • Polyclav 250mg/125mg Tablet
    6 tablets
    Macleods Pharmaceuticals Pvt Ltd
    ₹ 68.4
    50% offMRP₹ 136.7
    pay 24% more per Tablet
  • Mox CV 375 Tablet
    10 tablets
    Sun Pharmaceutical Industries Ltd
    ₹ 132
    50% offMRP₹ 264
    pay 44% more per Tablet
  • Novamox CV 250mg/125mg Tablet
    10 tablets
    Cipla Ltd
    ₹ 112
    50% offMRP₹ 223.85
    pay 22% more per Tablet
  • Augmentin 375 Tablet
    10 tablets
    Glaxo SmithKline Pharmaceuticals Ltd
    ₹ 115
    50% offMRP₹ 229
    pay 25% more per Tablet
  • Amoxyclav 375 Tablet
    10 tablets
    Abbott
    ₹ 134
    50% offMRP₹ 268.18
    pay 46% more per Tablet
  • Indclav 375 Tablet
    10 tablets
    Indchemie Health Specialities Pvt Ltd
    ₹ 95
    50% offMRP₹ 190
    pay 4% more per Tablet
  • Megamox-CV 375 Tablet
    10 tablets
    Abbott
    ₹ 72.6
    50% offMRP₹ 145.2
    save 21% more per Tablet
  • Clavituf 375mg Tablet
    10 tablets
    Intas Pharmaceuticals Ltd
    ₹ 70
    50% offMRP₹ 140
    save 24% more per Tablet
  • Amclaid 250mg/125mg Tablet
    6 tablets
    Indoco Remedies Ltd
    ₹ 67.5
    50% offMRP₹ 135
    pay 23% more per Tablet
Load More